The Bill & Melinda Gates Foundation has awarded $3.28 million to Seventh Sense Biosystems as part of a foundation program that is intended to increase developing countries' access to diagnostic tools. The company will use the money to develop a version of its Touch Activated Phlebotomy device that allows the collection of more blood.
Mass. diagnostics firm wins $3.28M from Gates Foundation
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||